Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy

Additional Metadata
Keywords	Radionuclide therapy, RGD, RGD-DTPA-Tyr3-octreotate, Scintigraphy, Tyr3-octreotate
Persistent URL	doi.org/10.1089/108497804323071940, hdl.handle.net/1765/61484
Journal	Cancer Biotherapy and Radiopharmaceuticals
Organisation	Department of Immunology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Bernard, B., Capello, A., van Hagen, M., Breeman, W., Srinivasan, A., Schmidt, M., Erion, J., van Gameren, A., Krenning, E.& de Jong, M. (2004). Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy. Cancer Biotherapy and Radiopharmaceuticals, 19(2), 173–180.https://doi.org/10.1089/108497804323071940

Publication